drugset / Trial / NCT01012310
Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and toleration of single and multiple doses of PF-04531083. (To investigate the plasma and urinary pharmacokinetics of PF-04531083 and its metabolites, following single and multiple dose administration in healthy male and/or female subjects; and to determine whether PF-04531083 raises levels of enzymes involved in metabolism of other drugs following multiple dosing).
Timeline
- Start
- 2009-11
- Primary completion
- 2010-02
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04531083 | Small molecule | 100 mg | Oral |
| Subject | PF-04531083 | Small molecule | 300 mg | Oral |
| Subject | PF-04531083 | Small molecule | 500 mg | Oral |
Indications
No indication recorded.